281 related articles for article (PubMed ID: 26394025)
21. Effect of S-aspirin, a novel hydrogen-sulfide-releasing aspirin (ACS14), on atherosclerosis in apoE-deficient mice.
Zhang H; Guo C; Zhang A; Fan Y; Gu T; Wu D; Sparatore A; Wang C
Eur J Pharmacol; 2012 Dec; 697(1-3):106-16. PubMed ID: 23085268
[TBL] [Abstract][Full Text] [Related]
22. Gastrointestinal safety of nitric oxide-derived aspirin is related to inhibition of ICE-like cysteine proteases in rats.
Fiorucci S; Antonelli E; Santucci L; Morelli O; Miglietti M; Federici B; Mannucci R; Del Soldato P; Morelli A
Gastroenterology; 1999 May; 116(5):1089-106. PubMed ID: 10220501
[TBL] [Abstract][Full Text] [Related]
23. Gastrointestinal-sparing effects of novel NSAIDs in rats with compromised mucosal defence.
Blackler R; Syer S; Bolla M; Ongini E; Wallace JL
PLoS One; 2012; 7(4):e35196. PubMed ID: 22496907
[TBL] [Abstract][Full Text] [Related]
24. Nitric oxide-releasing aspirin protects gastric mucosa against ethanol damage in rats with functional ablation of sensory nerves.
Konturek PC; Brzozowski T; Kania J; Konturek SJ; Hahn EG
Inflamm Res; 2003 Sep; 52(9):359-65. PubMed ID: 14504662
[TBL] [Abstract][Full Text] [Related]
25. H(2)S-releasing aspirin protects against aspirin-induced gastric injury via reducing oxidative stress.
Liu L; Cui J; Song CJ; Bian JS; Sparatore A; Soldato PD; Wang XY; Yan CD
PLoS One; 2012; 7(9):e46301. PubMed ID: 23029468
[TBL] [Abstract][Full Text] [Related]
26. Gastrointestinal safety, chemotherapeutic potential, and classic pharmacological profile of NOSH-naproxen (AVT-219) a dual NO- and H2S-releasing hybrid.
Chattopadhyay M; Kodela R; Duvalsaint PL; Kashfi K
Pharmacol Res Perspect; 2016 Apr; 4(2):e00224. PubMed ID: 27069635
[TBL] [Abstract][Full Text] [Related]
27. Gastric-sparing nitric oxide-releasable 'true' prodrugs of aspirin and naproxen.
Gund M; Gaikwad P; Borhade N; Burhan A; Desai DC; Sharma A; Dhiman M; Patil M; Sheikh J; Thakre G; Tipparam SG; Sharma S; Nemmani KVS; Satyam A
Bioorg Med Chem Lett; 2014 Dec; 24(24):5587-5592. PubMed ID: 25466180
[TBL] [Abstract][Full Text] [Related]
28. Nitric oxide (NO)-releasing aspirin exhibits a potent esophagoprotection in experimental model of acute reflux esophagitis. Role of nitric oxide and proinflammatory cytokines.
Pawlik M; Pajdo R; Kwiecien S; Ptak-Belowska A; Sliwowski Z; Mazurkiewicz-Janik M; Konturek SJ; Pawlik WW; Brzozowski T
J Physiol Pharmacol; 2011 Feb; 62(1):75-86. PubMed ID: 21451212
[TBL] [Abstract][Full Text] [Related]
29. Gastrointestinal safety and anti-inflammatory effects of a hydrogen sulfide-releasing diclofenac derivative in the rat.
Wallace JL; Caliendo G; Santagada V; Cirino G; Fiorucci S
Gastroenterology; 2007 Jan; 132(1):261-71. PubMed ID: 17241876
[TBL] [Abstract][Full Text] [Related]
30. Hydrogen sulfide inhibits human platelet aggregation in vitro in part by interfering gap junction channels: effects of ACS14, a hydrogen sulfide-releasing aspirin.
Gao L; Cheng C; Sparatore A; Zhang H; Wang C
Heart Lung Circ; 2015 Jan; 24(1):77-85. PubMed ID: 25047282
[TBL] [Abstract][Full Text] [Related]
31. NSAIDs, coxibs, CINOD and H2S-releasing NSAIDs: what lies beyond the horizon.
Fiorucci S; Santucci L; Distrutti E
Dig Liver Dis; 2007 Dec; 39(12):1043-51. PubMed ID: 17997373
[TBL] [Abstract][Full Text] [Related]
32. Enhanced Analgesic Effects and Gastrointestinal Safety of a Novel, Hydrogen Sulfide-Releasing Anti-Inflammatory Drug (ATB-352): A Role for Endogenous Cannabinoids.
Costa SKPF; Muscara MN; Allain T; Dallazen J; Gonzaga L; Buret AG; Vaughan DJ; Fowler CJ; de Nucci G; Wallace JL
Antioxid Redox Signal; 2020 Nov; 33(14):1003-1009. PubMed ID: 32064887
[No Abstract] [Full Text] [Related]
33. Colon cancer chemoprevention by a novel NO chimera that shows anti-inflammatory and antiproliferative activity in vitro and in vivo.
Hagos GK; Carroll RE; Kouznetsova T; Li Q; Toader V; Fernandez PA; Swanson SM; Thatcher GR
Mol Cancer Ther; 2007 Aug; 6(8):2230-9. PubMed ID: 17699720
[TBL] [Abstract][Full Text] [Related]
34. Hydrogen sulfide-releasing naproxen suppresses colon cancer cell growth and inhibits NF-κB signaling.
Kodela R; Nath N; Chattopadhyay M; Nesbitt DE; Velázquez-Martínez CA; Kashfi K
Drug Des Devel Ther; 2015; 9():4873-82. PubMed ID: 26346117
[TBL] [Abstract][Full Text] [Related]
35. Implications of reactive oxygen species and cytokines in gastroprotection against stress-induced gastric damage by nitric oxide releasing aspirin.
Brzozowski T; Konturek P; Konturek SJ; Kwiecień S; Sliwowski Z; Pajdo R; Duda A; Ptak A; Hahn EG
Int J Colorectal Dis; 2003 Jul; 18(4):320-9. PubMed ID: 12774247
[TBL] [Abstract][Full Text] [Related]
36. Physiological healing of chronic gastric ulcer is not impaired by the hydrogen sulphide (H
Korbut E; Suski M; Śliwowski Z; Bakalarz D; Głowacka U; Wójcik-Grzybek D; Ginter G; Krukowska K; Brzozowski T; Magierowski M; Wallace JL; Magierowska K
Inflammopharmacology; 2024 Jun; 32(3):2049-2060. PubMed ID: 38570398
[TBL] [Abstract][Full Text] [Related]
37. The novel anti-inflammatory agent VA694, endowed with both NO-releasing and COX2-selective inhibiting properties, exhibits NO-mediated positive effects on blood pressure, coronary flow and endothelium in an experimental model of hypertension and endothelial dysfunction.
Martelli A; Testai L; Anzini M; Cappelli A; Di Capua A; Biava M; Poce G; Consalvi S; Giordani A; Caselli G; Rovati L; Ghelardini C; Patrignani P; Sautebin L; Breschi MC; Calderone V
Pharmacol Res; 2013 Dec; 78():1-9. PubMed ID: 24083950
[TBL] [Abstract][Full Text] [Related]
38. Markedly reduced toxicity of a hydrogen sulphide-releasing derivative of naproxen (ATB-346).
Wallace JL; Caliendo G; Santagada V; Cirino G
Br J Pharmacol; 2010 Mar; 159(6):1236-46. PubMed ID: 20128814
[TBL] [Abstract][Full Text] [Related]
39. Effect of aspirin, paracetamol and their nitric oxide donating derivatives on exudate cytokine and PGE2 production in zymosan-induced air pouch inflammation in rats.
Mamuk S; Melli M
Eur J Pharmacol; 2007 Apr; 561(1-3):220-5. PubMed ID: 17320862
[TBL] [Abstract][Full Text] [Related]
40. Gastrointestinal safety of NO-aspirin (NCX-4016) in healthy human volunteers: a proof of concept endoscopic study.
Fiorucci S; Santucci L; Gresele P; Faccino RM; Del Soldato P; Morelli A
Gastroenterology; 2003 Mar; 124(3):600-7. PubMed ID: 12612897
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
